Table 3.
IL-6 | (a) Whole population |
(b) No MetS |
(c) MetS |
|||
---|---|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Model 1 | 2.28 (1.57–3.32) | 0.000 | 1.55 (0.85–2.845) | 0.155 | 3.17 (1.92–5.21) | 0.001 |
Model 2 | 2.13 (1.40–3.25) | 0.001 | 1.76 (0.89–3.47) | 0.105 | 2.65 (1.53–4.61) | 0.001 |
Model 3 | 2.14* (1.25–3.66) | 0.005 | 1.57** (0.66–3.77) | 0.309 | 2.91 *** (1.44–5.90) | 0.003 |
Model 4 | 2.12 (1.24–3.63) | 0.006 | 1.6 (0.67–3.98) | 0.028 | 2.86 (1.41–5.81) | 0.004 |
Model 5 | 2.18 (1.26–3.78) | 0.006 | 1.58 (0.66–3.81) | 0.304 | 3.167 (1.49–6.75) | 0.003 |
Model 1: adjusted for sex and age. Model 2: model 1 + physical activity, morbidities, diabetes mellitus type II. Model 3: model 2 + TSH, albumin, HbA1c, smoking, alcohol intake, professional education years, total energy intake/day. Model 4: model 3 + high IL-10 concentrations (tertile 3). Model 5: model 3 + low IL-10 concentrations (tertile 1). ALMBMI, ALM-to-BMI ratio; IL, interleukin; MetS, metabolic syndrome; TSH, thyroid-stimulating hormone; OR, odds ratio.
R2 = 0.178, Cohens f = 0.22.
R2 = 0.169, Cohens f = 0.2.
R2 = 0.190, Cohens f = 0.24.